Clinical Trial Update: Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the triplet regimen ixazomib plus lenalidomide plus dexamethasone in newly diagnosed multiple myeloma; status: active not recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• NINLARO (ixazomib)
• Revlimid (lenalidomide)

Snippet

Sponsor: Raija Silvennoinen | Conditions: Multiple Myeloma | Phase 2 | Status: ACTIVE_NOT_RECRUITING